Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018

Page created by Jill Ingram
 
CONTINUE READING
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
Daniel Matlow, President & CEO
                    TSXV VHI

CONFIDENTIAL • NOT FOR REDISTRIBUTION • MARCH 2018   TSXV VHI
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
Reader’s Advisory (1 of 2)
This corporate presentation dated October 2017 (the “Presentation”) has been prepared by management of Vitalhub Corp. (the “Corporation”), and is
based on public information and the Corporation’s confidential information. This Presentation is for information purposes only and is being made
available on a confidential basis solely to enable the prospective “accredited” and other qualified investors authorized by the Corporation to evaluate
the securities of the Corporation (the “Securities”). This Presentation does not constitute an offer to sell to any person, or a general offer to the public
of, or the general solicitation from the public of offers to subscribe or purchase, any of the Securities. Any unauthorized use of this Presentation is
strictly prohibited. Distribution or copying of this Presentation, in whole or in part in any medium, to any person other than the prospective investor is
prohibited without the prior written consent of the Corporation. The information contained in these slides, the Presentation made to you verbally and
any other information provided to you (in writing or otherwise) in connection with the Corporation and its business (the “Presentation Materials”) is
subject to updating, completion, revision, verification and amendment without notice which may result in material changes. The Presentation
Materials are not intended to provide financial, tax, legal or accounting advice and do not purport to contain all the information that a prospective
investor may require. Each prospective investor should perform and rely on its own investigation and analysis of the Corporation and the terms of any
offering of the Securities, including the merits and risks involved, and are advised to seek their own professional advice on the legal, financial and
taxation consequences of making an investment in the Corporation. The Securities are highly speculative.

No securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon the Presentation Materials, and any
representation to the contrary is an offence. Neither the Corporation nor any agent of the Corporation makes any representation or warranty,
express or implied, and assumes no responsibility for the accuracy or completeness of the information contained in the Presentation Materials or any
other oral or written communication transmitted to prospective investors, and nothing contained in this summary is, or shall be relied upon as, a
promise or representation by the Corporation or any agent of the Corporation as to the past or future performance of the Corporation. The
Corporation does not undertake to provide any additional further information or to enter into negotiations regarding the investment opportunity to
which these Presentation Materials relate. The Corporation retains the right, at any time, to terminate any discussions or negotiations with
prospective investors. In the event of such termination the Corporation will not be under any obligation to disclose the reasons for such termination
nor will they have any liability to any recipient hereof for any costs whatsoever incurred in the consideration of the information contained in these
Presentation Materials.

2                                                                                                                       TSX.V V H I
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
Reader’s Advisory (2 of 2)
This presentation contains forward-looking statements. Often, but not always, forward-looking statements can be identified by the use of words such
as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or “recurring” or
variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward looking statements contained in this Presentation may include, but are not limited to statements with respect to the successful
execution of the Corporation's business strategy (including its business model. M&A strategy and mission), the use and benefits of its products and
services, the Corporation’s favourable position in the market on a go-forward basis, demographic and market size/trends, forecasts of revenue and
financial projections/growth potential/opportunities, the completion of proposed acquisitions of target companies, the use of proceeds from the sale
of the Corporation’s Securities, competitive analysis, proposed synergies, projected milestones, go-forward management of the Corporation, and
other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance, expected regulatory filings,
review and approval dates, construction and start-up timelines and schedules, and statements related to the continued overall advancement of the
Corporation’s projects. Forward-looking statements involve known and unknown risks, uncertainties and other factors, such as competition,
technological changes, the changing needs of hospitals, the financial condition of Vitalhub’s current and potential customers, foreign currency
exchange rates, as well as general economic conditions, which may cause the actual results, performance or achievements of Vitalhub to be materially
different from any future results, performance or achievements expressed or implied by the forward-looking statements. Actual results and
developments are likely to differ, and may differ materially, from those expressed or implied by the forward-looking statements contained in this
presentation.

There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from
those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The forward looking
statements contained in this presentation are made as of the date hereof or the dates specifically referenced in this presentation, where applicable.
Except as required by law, the Corporation undertakes no obligation to update publicly or to revise any forward looking statements that are contained
or incorporated in this presentation. All forward looking statements contained in this presentation are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this presentation.

3                                                                                                                      TSX.V V H I
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
VitalHub Inc. – Company Overview

• High-growth strategy through the introduction of Blockchain Healthcare Solutions using the
  Hyperledger Platform, combined with a reliable/profitable M&A “hedge” strategy
• New RTO completed in December 2016 (ticker VHI.V)
• SaaS-based, high-margin products that can be sold organically across the digital health
  marketplace, and cross-sold into acquired-companies’ install bases
• Management team and Board of Directors with proven success operating a publicly traded,
  Canadian-based Healthcare IT company
• Offshore research and development (“R&D”) strategy that cuts costs, increases margins, and
  produces synergized businesses and products offerings

4                                                                             TSX.V V H I
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
VitalHub Inc. – Company Principals
              Dan Matlow                                                    Vijit Coomera                                           Peter Catford
       (CEO and Founder, Medworxx)                                   (Co-Founder and CTO, B Sharp)                        (Co-Founder and CEO of HInext Inc.)
• 30 years experience in technology field with focus          • 30 years experience in development and tech               • 30+ of experience in healthcare information
  on Health IT                                                • Extremely technically savvy, developing innovative          systems development
• Track record of building and growing enterprise               and disruptive technology solutions                       • Developed EHR software system installed in
  software companies                                          • Managed technological and architectural software            85 organizations across N.A.
• Strong sales, marketing, and investor relations skills        dev. of multiple projects across N.A. and Europe          • Adjunct Faculty UofT; informatics in the
• Proven ability to grow internationally                      • Oversaw establishment of dev. hub in Sri Lanka              Masters of Health Admin program (MHSc)
• Deep knowledge of the Healthcare IT marketplace                                                                         • Past Chair of Ontario’s Health Informatics
                                                                                                                            Standards Council (OHISC)

Brian Goffenberg CA, CPA                            Robert Lazar                                 Niels Tofting                         Andre Vandenberk
     (CFO, Medworxx)                         (Co-Founder & CEO, B Sharp)                       (VP Sales, Logibec)                      (CTO, Medworxx)
• 30 years experience, multiple CFO        • 28 years experience                        • 20 years of software experience       • Deep understanding of Healthcare IT
  roles including Philips Lifeline         • Expertise driving company performance      • Developed and managed high-           • Technology visionary
  (Canada), DWL, etc.                        through post-sales management                performing sales teams Success        • 20 years experience in Product
• Strong public market experience          • Proven track record building both client     supporting diverse vertical markets     Development
• Proven results-driven track record         and business partnership relationships     • Experience leading international      • Strong ability to communicate
• Extensive financial governance           • IT consulting for $6B distributor and        business development and growth         business value to an IT audience
  skills and experience                      retailer

5                                                                                                                                 TSX.V V H I
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
Medworxx History

•   International Healthcare IT company that was publicly traded on the TSX.V
•   Unique Patient Flow solutions originating from use at Canadian hospitals
•   Solutions are used by over 70% of hospitals across Canada
•   Grew internationally to over $8 million in revenue across five countries
•   Share price grew from 5 cents in 2008 to 60 cents in 2015 (CAGR 30% beds under license)
•   Sold to Aptean, a subsidiary of Vista Equity Partners, in October 2015 for a valuation
    of $20 million

6                                                                      TSX.V V H I
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
VitalHub Inc. – Board of Directors
    Dan Matlow                                  Mohan Plakkot                                         Chris Schnarr
    • President and CEO Vitalhub Inc.           • Partner and Chief Strategist at Valsef Capital, a   • Managing Director of Lorian Group Inc.
    • 30 years experience                         private investment company focusing on public       • 25 years public company and board experience
    • Former Founder and CEO of Medworxx Inc.     software companies                                    across a range of roles and industries
      Proven Healthcare IT executive            • Experience in fortune 500 financial software        • Currently Director, Chair of the Audit
                                                  and services company                                  Committee, and member of the Governance
    • Strong sales, marketing, and investor
      relations skills                          • MBA in Strategy and Finance, with experience          and Compensation Committees of Canopy
    • Proven ability to grow internationally      in structuring M&A transactions for internet          Growth Corporation and Intrinsic 4D Inc.
                                                  assets

    Roger Dent                                  Barry Tissenbaum                                      Steve Garrington
    • Chief Executive and Director of           • Retired fmr. Senior Partner with Ernst & Young      • Former Director of 3 public companies listed
      Quinsam Capital Corporation               • Currently serves on the Noranda Income Fund           on Canadian, Australian, and UK exchanges
    • Director of Acuity Ads Holdings Inc.        Board, and is Chairman of the Audit Committee       • Executive Vice President InterSystems Inc.
    • Former Portfolio Manager with Matrix      • Served on boards of many private and public         • 30 years of Healthcare IT Experience with
      Fund Management                             companies providing strategic accounting              a vast amount of International experience
    • Former Director of research for CIBC        governance
      World Markets

7                                                                                                                  TSX.V V H I
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
VitalHub Timeline

    2014                     2016                    2017               JAN 2018                CURRENT
VitalHub grew out    Purchased by key former   Acquired B-Sharp       Acquired H.I. Next       Introduction of
of a collaboration   members of the            Technologies, 24-      Inc., large US install   Healthcare Blockchain
between Mount        Medworxx management       person offshore        base, As of Jan 2018     solutions, built on the
Sinai Hospital in    team in May of 2016       development team,      it has since been        Hyperledger Platform
Toronto and MaRS                               currently generating   generating CAD 3.1M
Innovation           Closing of qualifying     CAD $1.4M in           in annual revenue,
                     transaction and           recurring revenue      $2.4M in recurring
                     public offering                                  revenue

8                                                                                        TSX.V V H I
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
The digital healthcare marketplace has
Blockchain Solutions                                                                         experienced transformative growth over
      to Healthcare                                                                          the past 15 years, redefining the delivery
                                                                                                 of care. This comes with extreme
         Challenges                                                                               pressure to regulate costs while
                                                                                              providing high-quality care to patients.

   The problem is that growing                                                                Blockchain applications can benefit the
demand for healthcare services and                                                               healthcare ecosystem as a whole,
integrated-care delivery creates an                                                         alleviating several major challenges to the
 unaddressed need for information                                                           industry; supporting seamless information
 technology solutions that remove                                                           sharing that can eliminate the duplication,
   middlemen, reduce costs, and                                                              errors and inconsistencies that arise with
   promote privacy and security.                                                                traditional, centralized data storage.

9   (Source: Dash, Majumdar, and Gunjikar, “Blockchain: A Healthcare Industry View”, Capgemini 2017.)              TSX.V V H I
Daniel Matlow, President & CEO - TSXV VHI CONFIDENTIAL NOT FOR REDISTRIBUTION MARCH 2018 - March 4 2018
Blockchain Technology for Healthcare Industry

     M&A – Buying Assessment-
     Based Assets                                            Explosive
                                                              Growth
     Blockchain – Future
     Healthcare Solutions                     Expectation:
                                             $1M+ Projects
LEGEND
Phase I: Proof of Concept/            Early
Pilot Projects                     Profitability
Phase II: Production Use
Phase III: Full-Scale Production
($1M+ Gov’t & Int’l Projects)

10                                                               TSX.V V H I
Healthcare – Explosive Blockchain Opportunity

 Barriers limiting the effective   Siloed Healthcare    Unlocking Siloed Healthcare
 use and accessibility of siloed      Information        Information Securely with a
     healthcare databases                              Decentralized Encrypted Ledger

11                                                              TSX.V V H I
Validation – Blockchain Technology in Healthcare

“Blockchain solutions for financial services have received the maximum investments.
Healthcare has the most aggressive plans to deploy Blockchain-based applications across
multiple use cases during 2017.” (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.)

“Blockchain technologies hold the promise to unite the disparate processes in healthcare,
increase data flow and liquidity, reduce costs, and improve patient experience and
outcomes.” (Source: “The Potential for Blockchain Technology in Health IT”, HIMSS, March 1 2017)

“[…] We believe Blockchain has a huge potential to become the next big technology-
innovation engine. Blockchain applications for patient-data portability, interoperability, care-
delivery management, and administration can provide the answers to make challenges facing
the industry.” (Source: “Blockchain: A Healthcare Industry View”, (Source: Dash, Majumdar, and Gunjikar,
“Blockchain: A Healthcare Industry View”, Capgemini 2017.)

12                                                                                                TSX.V V H I
Blockchain Technology for Healthcare Industry
Top 5 Growth Opportunities by Use-Case, Global, 2016–2025
Use Cases

                  Healthcare Data Exchange            Claims Adjudication &                Drug Supply Chain Integrity           Clinical Trails and Population      Cyber Security and Internet
                  and Interoperability                Billing Management                   and Remote Auditing                   Health Research                     of Medical Things (IoMT)

                 Provide access to historic and        New product venture like DAO-       Drug supply chain provenance at       Manage IP and assets transactions   Encryption and permanent ledger
                 real-time patient data on             based peer-to-peer insurance        individual product/drug level         on Blockchain                       of patient-generated health data
                 Blockchain
                                                       Decentralized                       Blockchain-based remote               Reduce outcome switching, data      Medical device data integration
                 Identity management with              marketplace                         processes auditing with verifiable    snooping, and selective reporting   and security to enable
 Key Benefits

                 predefined user access rules for                                          source of truth                                                           remote/home care
                                                       Automate underwriting                                                     Better and faster regulatory
                 P2P networking
                                                       and policy insurance                Improve pharma supply                 compliance and approvals            Unique identifiers for medical
                 Store genomics and user-                                                  chain finance                                                             devices or assets on Blockchain
                                                       Improve claimant and                                                      Bilateral interactions and
                 generated data securely, with                                                                                                                       shared ledger system to automate
                                                       beneficiary KYC                     More visibility for marketing         communication with all industry
                 access control                                                                                                                                      maintenance and management
                                                                                           efforts and medication                participants
                                                       Automate claim processing
                 Maintain universal health                                                 adherence programs
                 records and identities                Reduce admin costs
Impact*

                           $18.5 B                               $97.5 B                               $200 B                               $25.5 B                              $5.2 B
                *Impact: Indicates the potential cost saving opportunities with successful deployment of Blockchain across these 5 use cases globally.

13              (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.)                                                 TSX.V V H I
Use Case 1 – Healthcare Data Exchange & Interoperability

At its core, Blockchain would offer the potential of a shared platform that decentralizes health data
ensuring access control, authenticity, and integrity of protected health information.

               Interoperability Gaps: Lack of interoperability costs 150,000 lives and $18.6 billion per year.
Challenges
 Current

               Need for Longitudinal Health Records: 46% of US clinicians do not have a complete view of their patients’
               health history/ records. Further, individuals cannot view a unified medical record or pass it on to clinicians.
               High Error Rates with Centralized Health IT Systems: Error rates for successfully identification or integration of
               a file are 25% for hospitals and health systems; and as high as 50%–60% outside hospitals.

Key Blockchain Features
Access to historic and real-time patient data on Blockchain, cryptographically secure
and irrevocable or immutable.
Identity management with predefined user access rules peer-to-peer network;
multi-party collaboration health bank for remunerative commons.
Storage of genomics and user- generated data securely with access control.

14    (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.)   TSX.V V H I
Use Case 1 – Healthcare Data Exchange & Interoperability

(i)     Blockchain-enabled health IT systems that can provide technological solutions to many
        challenges, including health data interoperability, integrity and security, portable user-
        owned data and other areas.

(ii)    Blockchain could enable data exchange systems that are cryptographically secured and
        irrevocable, enabling seamless access to historic and real-time patient data, while
        eliminating the burden and cost of data reconciliation.

(iii) The recent collaboration between Guardtime, the data-centric
      security company, and the Estonian eHealth Foundation to
      secure the health records of one million Estonian citizens
      using its proprietary Keyless Signature Infrastructure (KSI)
      is a classic example of Blockchain technology.

15     (Source: "Does Blockchain Have A Place In Healthcare?" Forbes, www.forbes.com, May 8, 2017.)   TSX.V V H I
Distribution Strategy

System Integrators
Vendors/Consulting Partners
                              Direct Sales
                              Management team has successfully
                              sold internationally through system
                              integrators, and has proven large
                              project implementation skills.

                              VitalHub’s entire platform is being built
                              on Hyperledger Technology Set.

16                                              TSX.V V H I
Blockchain Pricing Strategy

         Recurring Revenue Stream
     $   • BaaS-based, long-term annual-use   Blockchain as a Service (BaaS)
           contracts (i.e. 5-years)
         • Annual fees based on usage and
           amount of data
         • High-margin products
                                                            Expectation:
                                                       Blockchain projects
                                                       will be large in nature

     $
         One Time Consulting Fees                     Large government and
         • One-time and ongoing                       international projects
                                                         (large in nature)
         • Implementation and Training
         • Best practice and advisory
           consulting fees
17                                                          TSX.V V H I
M&A Strategy
VitalHub’s strategy is to rapidly increase growth and profitability by combining like software
companies focused in the Healthcare IT area

                                                                                                                  Global mHealth market
                                                                                                                  projection 22% CAGR

Reduce R&D Spend        Consolidate G&A     Optimize S&M        Cross-Selling Products Build Mobile Solutions       Sell Organically
 Reduction of R&D       Consolidation of    Implementation        Upselling VitalHub   Create mobile versions       Develop and sell
costs by moving dev        finance and     of effective sales     mHealth platform      of legacy apps mobile        new VitalHub
   offshore with a       administration      and marketing         into install base   and upsell into existing    products into large
significantly reduced     into a central       processes                                     install bases          growth markets
   wage structure        functional area

18                                                                                                  TSX.V V H I
M&A Strategy

  Have identified 15 companies              Target companies are synergistic with annual
                                                                                            Combination of cash and stock
                                           revenues of $1M-$7M, profitable with limited
 primarily in Canada, UK and Australia                                                        using the public markets
                                          growth, and have not adopted a mobile strategy
       that are looking for exits

            20%                                 20%-30%                                     1.0-2.5x
 Reduce costs by 20% through             Target 20%-30% EBITDA with cross-selling           Purchase companies between
synergistic reductions and utilization      and synergistic cost reductions including      1.0x-2.5x revenue   multiple
of cost effective offshore resources         effective offshore development work

19   VitalHub mHealth solution will be sold to target install bases                          TSX.V V H I
Target Companies – Acquisition Characteristics
Target Companies possess these qualities
• Recurring revenue above 60% of total revenue
• Breakeven or profitable
• Owner operated businesses with limited outside investment
• Large component of expense is on research and
  development vs. sales and marketing
• Little commercialization or sales and marketing expertise
• Significant customer base with minimal retention issues
• Limited or no expansion beyond geographical boundaries
  creating a large growth barrier
• Ability to upsell to existing install bases of target companies
  by bringing their product into a mobile environment

20                                                                  TSX.V V H I
VitalHub – Acquisition #1
 1. Mobile health enterprise software   4. Over $7M invested in R&D since inception
    solutions vendor                    5. Roots within MaRS and Mount Sinai
 2. Current revenues of $560k              hospital in Toronto
    per annum                           6. Recent Sales and Marketing initiatives
 3. $490k annual recurring revenue         driving growing pipeline

21                                                                TSX.V V H I
VitalHub – The Integrated Mobility Solution

VitalHub acts as a bridge, aggregating, consolidating, and
porting data from siloed legacy health systems into an easy
to use mobile format.

VitalHub is an innovative solution that provides hospitals and
vendors with an enabling technology that integrates and
optimizes information across existing digital health systems.

Strong mobility IP allows the data of siloed legacy health
systems to be made easily available for mobile consumption,
simplifying availability and access for clinicians.

22                                                               TSX.V V H I
VitalHub’s mHealth Solution
      VH Chart
  Real-time patient                                                    VH Physician Onboarding
 information at the                                                    Communicate with all your
point of need on any                                                    physicians using mobile
   mobile device                                                       devices for easy physician
                                                                         onboard and ongoing
                   VH Engage           VitalHub packages information     target communication
              Communication tools         and data, making it more
               enabling hospitals to      accessible for mobile use
              interact with patients
                   and families                                                            VH Task Manager
                                                                                            Assign, schedule
                                                                                        and monitor employee
      VH Family Portal                                                                   tasks in all healthcare
 Providing family members                                                                    settings using
with real-time information on                                                                mobile devices
the health and mental status
     of their loved ones

    23                                                                           TSX.V V H I
Acquisition #2: B Sharp Technologies (Oct 2017)
• 20 year old Canadian company
• $2.3 million (CAD) annual revenue                                                                                               40 Canadian
• $1.5 million (CAD) recurring revenue                                                                                            Hospital
• CEO and CTO possess strong app                                                                                                  Customers
  development and operational skills
  and will join management team
• Domain and healthcare development expertise

Five Products with an Emphasis on Mental Health
• Cardiac Electronic Health Records
• Mental Health EHR solution
• Long term Care EHR solution
• Pharmacy Solution
• AIDS EHR
     Source: Information provided by B Sharp Technologies and has not been independently verified by the Corporation.
     The Corporation or its agents undertake no obligation to comment on analysis, expectations or statements made by
24   third parties in relation to B Sharp Technologies, its security or their respective financial or operating results.   TSX.V V H I
B Sharp Technologies: Offshore Development Team

Twenty-four member offshore development team                                                                               Colombo, Sri Lanka
located in Sri Lanka

        Strong offshore base to develop and
        grow Blockchain solutions

Characteristics
•    In operation since 2008
•    Team of 24 developers
•    Average salary of $18k (CAD) per year
•    Average tenure of 4 years
•    Total cost of operation is $600k (CAD) per year                                                                       24 Member Offshore
                                                                                                                           Development Team
     Source: Information provided by B Sharp Technologies and has not been independently verified by the Corporation.
     The Corporation or its agents undertake no obligation to comment on analysis, expectations or statements made by
25   third parties in relation to B Sharp Technologies, its security or their respective financial or operating results.   TSX.V V H I
Acquisition #3: H.I. Next Inc. (Jan 2018)
• 19 year old company with large U.S. install                                                                      U.S. business primary growth area
• 80 Behavioral Health Institution Customers
• $3.1 million (CAD) annual revenue
• $2.4 million (CAD) recurring revenue
• Mental Health EHR sold both in Canada and the U.S.
• CEO is the former CIO of CAMH with large
  knowledge base especially in the mental health area
• Strong U.S. partner driving sales
• Opportunity to significantly lower R&D costs
• Mental health and clinical domain expertise                                                                      40 U.S. Behavioral Health
Source: Information provided by H.I. Next Inc., and has not been independently verified by the
Corporation. The Corporation or its agents undertake no obligation to comment on analysis, expectations
                                                                                                                   Institution Customers
or statements made by third parties in relation to H.I. Next Inc., its security or their respective financial or
operating results.
                                                                                                                   +40 in Canada

26                                                                                                                             TSX.V V H I
M&A Synergies Result in EBITDA Growth

      Upsell VitalHub
      Mobility Solution to
      Target Companies’
      Install Bases
27                                TSX.V V H I
Estimated Capital Structure Post M&A

                                               Shares                         %
     Current Shareholding                  124,885,709                  100.0%
        Public                              78,835,166                   61.5%
        Management control                  48,050,543                   38.5%

     Total                                 124,885,709                  100.0%

             Approximately 21% of the public float is held by institutions.

28                                                                        TSX.V V H I
Post M&A – Estimated P&L (Pre-Blockchain)
                          % Revenue   % OPEX                       % Revenue             $

Revenue   $ 6,457,968        100%               Optimized S&M              100%      $ 10,000,000

OPEX      $ 6,940,504        107%       100%                                   65%   $ 6,500,000

S&M       $ 1,057,846          16%       15%   Consolidated G&A                15%   $ 1,500,000

G&A       $ 1,259,312          20%       18%                                   15%   $ 1,500,000

R&D       $ 4,623,346          72%       67%                                   35%   $ 3,500,000
                                               Reduced R&D Spend

Loss      $   (482,536)        -7%                                             35%   $ 3,500,000

29                                                                      TSX.V V H I
Comparable Companies

     $33M   $9.35      5.5x          $322M   $54.20   4.5x       $224M   $37.02   12.7x

     2.4B   $739.0      6.5x          $66M   $16.25   3.2x       $333M   $66.75    6.3x

30                  Revenue*   Share Price    Revenue multiple      TSX.V V H I
Recent Transaction – QHR: Canadian EMR Company (TSX.V)

                             QHR Operations
$30M

$20M

$10M

     $M
                   2013                2014                2015                  Sale

                          Revenue                  Net (loss) earnings

QHR recently announced its sale to Loblaws
for $170M – 5x multiple of revenue

Note: This transaction is in no way indicative of transactions currently available to or contemplated by the Corporation. The economics for the transaction presented in this slide, including the revenue
multiples and historical trading prices, are not typical and there can be no guarantee that the Corporation will be able to complete a similar transaction or any transaction at all.

31                                                                                                                                                                      TSX.V V H I
VitalHub Inc. – Summary

 • TSX.V listed Healthcare IT company creating innovative Blockchain technology platform

 • Proven management team and board with strong track record, ability to execute, and
   public markets experience
 • Focused M&A strategy positioned for rapid growth, with 15 potential acquisition
   targets identified (profitable “hedge” strategy, providing real downside protection)
 • Offshore R&D strategy that cuts costs, increases margins, improves efficiency; and enables
   the scalability, growth, and development of Blockchain solutions
32                                                                         TSX.V V H I
Statutory rights for subscribers resident in Ontario and Saskatchewan: (1/2)

Section 130.1 of the Securities Act (Ontario) (the “Ontario Act”) and Section 138 of the Securities Act
(Saskatchewan) (the “Saskatchewan Act”) provides that every purchaser of securities pursuant to an offering memorandum shall have a statutory right
of action for damages or rescission against the issuer and any selling security holder in the event that the offering memorandum contains any untrue
statement of a material fact or omits to contain a material fact that is required or that is necessary in order to make any statement herein or therein not
misleading in the light of the circumstances in which it was made (a “Misrepresentation”). A purchaser who purchases securities offered by the offering
memorandum during the period of distribution has, without regard to whether the purchaser relied upon the Misrepresentation, a right of action for
damages or, alternatively, while still the owner of the securities, for rescission against the issuer and any selling security holder provided that:
a) if the purchaser exercises its right of rescission, it shall cease to have a right of action for damages as against the issuer and the selling security
    holders, if any;
b) the issuer and the selling security holders, if any, will not be liable if they prove that the purchaser purchased the securities with knowledge of the
    Misrepresentation;
c) the issuer and the selling security holders, if any, will not be liable for all or any portion of damages that it proves do not represent the depreciation
    in value of the securities as a result of the Misrepresentation relied upon; and
d) in no case shall the amount recoverable exceed the price at which the securities were offered.

Section 138 of the Ontario Act, and Section 147 of the Saskatchewan Act provide that no action shall be commenced to enforce these rights more
than:
a) in the case of an action for rescission, 180 days from the day of the transaction that gave rise to the cause of action; or
b) in the case of an action for damages, the earlier of:
    I. 180 days from the day that the purchaser first had knowledge of the facts giving rise to the cause of action; or
    II. three years from the day of the transaction that gave rise to the cause of action.

33                                                                                                                      TSX.V V H I
Statutory rights for subscribers resident in Ontario and Saskatchewan: (2/2)

The rights referred to in section 130.1 of the Securities Act (Ontario) do not apply in respect of an offering memorandum delivered to a prospective
purchaser in connection with a distribution made in reliance on the exemption from the prospectus requirement in section 2.3 of National Instrument
45-106 (the “accredited investor” exemption) if the prospective purchaser is:

a) a Canadian financial institution or a Schedule Ill bank,
b) the Business Development Bank of Canada incorporated under the Business Development Bank
   of Canada Act (Canada), or
c) a subsidiary of any person referred to in paragraphs (a) and (b), if the person owns all of the voting securities of the subsidiary, except the voting
   securities required by law to be owned by directors of that subsidiary.

Pursuant to Section 80.1(3) of the Saskatchewan Act, a purchaser who has received an amended offering memorandum delivered in accordance with
subsection 80.1(3) of the Saskatchewan Act has a right to withdraw from the agreement to purchase the securities by delivering a notice to the
person who or company that is selling the securities, indicating the purchaser’s intention not to be bound by the purchase agreement, provided such
notice is delivered by the purchaser within two business days of receiving the amended offering memorandum.
Similar rights of rescission are available to subscribers resident in Alberta pursuant to the provisions of Section 204 of the Securities Act (Alberta).
Subscribers in Alberta are advised to consult the Securities Act (Alberta) for the specific language pertaining to their rights.

34                                                                                                                      TSX.V V H I
Appendix I: Future Adoption of Blockchain in Healthcare

Which solution/improvement has the most potential to drive Blockchain adoption
across the Healthcare industry?

                                                                               Interoperability of Electronic Health
                            42.9%
                                                                               Public Data Use cases (Provider Directory)
                                                   7.1%
                                                                               Claims

                 17.9%                                                         Other
                                           28.6%
                                                                               Eligibility
                           3.5%

35   (Source: January 2017 Hyperledger Healthcare Working Group Survey, N=28                                 TSX.V V H I
Appendix II: 6 Big Themes for Blockchain Technology in Healthcare

                                                                                                                            Cybersecurity
                                    Health Data Interoperability             Healthcare Business Models             Distributed network consensus
                                      Provide ubiquitous security              Transform the digital health          with cryptography techniques
                                      infrastructure for seamless            economy to create new business          provides an additional layer of
                                     health data exchange without               and monetization models             trust to minimize cybersecurity
                                        reconciliation or trusted                    for health asset                   threats for healthcare IT
                                               3rd party.                               exchange.                               systems.

     “Blockchain technology
      potential applications                                    Value-Based Care
     in some of the pressing                                  Trusted workflows with
                                                          “single source of truth” provide
                                                                                                   Healthcare Consumerism             Precision Medicine Practice
                                                                                                                                        Patients can permit access to
                                                                                                  Ensure co-creation of trust and
          needs of the                                      radical new possibilities for
                                                                                                  self- sovereignty for a patient-
                                                                                                                                         their anonymized personal
                                                                outcome-based care                                                     health information for research
      Healthcare industry.”                                 delivery and reimbursement
                                                                                                     centric Blockchain health
                                                                                                            ecosystem.
                                                                                                                                        commons and remunerative
                                                                      models.                                                                      models.

36   (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.)                                   TSX.V V H I
Appendix III: Adoption Timeline – Blockchain Healthcare Use Cases

Blockchain Technology Adoption Timeline Across Major Healthcare Applications/Use Cases, Global, 2016–2025
           Immediate (2016–2018)                                    Short-Term future (2018-2021)                              Long-Term future (2021-2025)
             Digital Identity Verification/                              IoMT (medical asset management                                      IoMT
                      Management                                            and device data exchange)                             (Quantified self, home care)

             National Medical/ Health                                       Smart Contracts (health vendors                        Universal Health Records
         Records (authenticity and integrity)                               RFPs and contract management)                               and Identities

        Drug Supply Chain Provenance (drug                                 Health Token (HSN, research,                        Genomics and User-generated Data
             counterfeiting and theft)                                         wellness incentives)                                      Management

             Claims Adjudication & Billing                  Managing Pharma/Biopharma IP and Assets Transactions                    Blockchain AI and AR/VR
                 Management/ RCM                                              on Blockchain                                               Applications

                    eConsenting                                                 Clinical Trials Records                           Blockchain-based Wellness,
             (Research and clinical trials)                                    Integrity and Exchange                                 Personal Coaching

             Healthcare Data Storage, Access,                          Regulatory Audit and Adverse Event                             Health Policy Voting
             and Analytics (on/off Blockchain)                                 Safety Monitoring

     Note: Blockchain system adoption across these healthcare use cases demonstrate more convincing opportunities, albeit at    Blockchain-based Learning Health
                                varying degrees of adoption across countries and health systems.                                     Systems and Advocates

 Certainty of Adoption High Medium Low
37      (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.)                               TSX.V V H I
Appendix IV: Use Case 2 – Claims Adjudication & Billing Management

About 6% of all medical claims are denied due to incomplete or incorrect information. The Blockchain
system could automate the claim process and dispel administration layers to reduce transaction costs
and frauds.

               Insurance notarization and medical billing frauds: An estimated 5%–10% of health care costs are fraudulent,
Challenges

               resulting from excessive billing or billing for non-performed services. For example, in the United States alone, a
 Current

               Medicare fraud scheme incurred about $30 million in losses during 2016.
               Inefficiencies with BIR activities: An estimated 15%–20% of health care spending and processing costs are
               associated with BIR activities. E.g., US BIR costs are projected to reach $315 billion dollars by 2018, up over
               100% from 2007.

Key Blockchain Features
Automates claim adjudication and payment processing.
Blockchain network consensus custody log to track each step of trustless exchange with predefined smart contracts.
Peer-to-peer insurance: Peer-evaluated and peer-adjudicated health claims.
Pay for outcomes and incentive-based behavioral health programs, leveraging smart contracting features.

38    (Source: "Blockchain Technology in Global Healthcare, 2017–2025", Frost & Sullivan, June 2017.)   TSX.V V H I
Appendix IV: Use Case 2 – Claims Adjudication & Billing Management

(i)     An estimated 5-10% of healthcare costs are fraudulent, resulting from excessive billing
        or billing for non-performed services.

(ii)    Blockchain-based systems can provide realistic solutions for minimizing these medical
        billing-related frauds; by automating the majority of claim adjudication and payment
        processing activities, Blockchain systems could help to eliminate the need for
        intermediaries and reduce the administrative costs and time for providers and payers.

(iii) Recently, Gem Health, a provider of Blockchain application platforms
      for enterprises, has collaborated with Capital One to develop
      Blockchain-based healthcare claims management solutions.

39     (Source: "Does Blockchain Have A Place In Healthcare?" Forbes, www.forbes.com, May 8, 2017.)   TSX.V V H I
You can also read